Home/Spotlight Medical/PhD Sylvain Berlemont
PS

PhD Sylvain Berlemont

Cofounder & Chief Executive Officer

Spotlight Medical

Therapeutic Areas

Spotlight Medical Pipeline

DrugIndicationPhase
AI-Powered Prognostic Assay for ER+/HER2- Early Breast CancerEarly-stage, Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Breast CancerValidated